Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma.

Cell transplantation - 1 Jan 2012

Motaln Helena, Gruden Kristina, Hren Matjaz, Schichor Christian, Primon Monika, Rotter Ana, Lah Tamara T

Abstract excerpt

In contrast to the application of human mesenchymal stem cells (hMSCs) in regenerative medicine, only a limited number of studies are addressing their use in anticancer therapy. As the latter may represent a new hope to improve the survival of patients with glioblastoma multiformae (GBM), the most common and malignant form of the brain tumors, we aimed to investigate the interactions of hMSCs and GBM cells under...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunomodulation
Share to Chemokine CCL2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokines

Share to Drug Combinations

Share to Laminin

Share to Paracrine Communication

Share to Protein Array Analysis

Share to Proteoglycans

Source

Identifiers

PMID: 22554389
DOI: 10.3727/096368912X640547

Genes

CCL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma.PMID 22554389Read ↗

Insights in the immunobiology of glioblastoma.Semantic proximity Read ↗

Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated MacrophagesSemantic proximity Read ↗

Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targetsSemantic proximity Read ↗

IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastomaSemantic proximity Read ↗

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastomaSemantic proximity Read ↗

The Dynamics of Interactions Among Immune and Glioblastoma Cells.Semantic proximity Read ↗

The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma CellsSemantic proximity Read ↗

Identification of Prognostic Biomarkers and Immunotherapeutic Targets with CXC Chemokines in Glioblastoma Multiforme Using Integrated Bioinformatic AnalysisSemantic proximity Read ↗

Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance.Semantic proximity Read ↗

The CXCL2/IL8/CXCR2 Pathway Is Relevant for Brain Tumor Malignancy and Endothelial Cell FunctionSemantic proximity Read ↗

Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.Semantic proximity Read ↗

Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.